Biotech
-
856Arrayit Corp (OTCMKTS: ARYC) Allergy Testing Services Gain Traction
Shares of Arrayit Corp (OTCMKTS: ARYC) have taken a flight ever since the company increased its weekly guidance for medical billing associated...
-
759Elite Pharmaceuticals Inc (OTCMKTS: ELTP): Bulls Must Defend To Avert Further Slides
Shares of Elite Pharmaceuticals Inc (OTCMKTS: ELTP) appear to have hit a critical resistance level if a recent pullback is anything to...
-
932What’s Next For Neurotrope Inc (NASDAQ: NTRP)?
Neurotrope Inc (NASDAQ: NTRP) is a biotech that we covered a lot back in 2017 when the stock was trading like a rocket...
-
1.4KWill Biogen Inc (NASDAQ: BIIB) Buy Anavex Life Sciences Corp (NASDAQ: AVXL)?
After the news broke last week that Biogen Inc (NASDAQ: BIIB) and development partner Eisai (OTCMKTS: ESALY) decided to terminate two late-stage studies,...
-
644Sorrento Therapeutics Inc (NASDAQ: SRNE) On The Move
Sorrento Therapeutics Inc (NASDAQ: SRNE) is a name that we last covered back in 2017. We talked about the stock when it...
-
1.1K1Predictive Technology Group Inc (OTCMKTS:PRED) Skyrocketing On 216% Revenue Growth
Shares of Predictive Technology Group Inc (OTCMKTS:PRED) have been flying, ever since the company reported a 216% increase in revenues. The stock...
-
572Nemus Biosciences Inc (OTCMKTS:NMUS) Breaks Out To New Highs
We said last month that Nemus Biosciences Inc (OTCMKTS:NMUS) was set for a breakout and boy were we right on the money. The...
-
669Atossa Genetics Inc (NASDAQ:ATOS) Squeezes The Shorts
Atossa Genetics Inc (NASDAQ:ATOS) is a name that we have covered quite a bit in the past here at Insider Financial. However,...
-
856Why Advaxis, Inc. (NASDAQ:ADXS) Is A ‘Buy’
Advaxis, Inc. (NASDAQ:ADXS) is one of the stocks that is attracting significant attention in the healthcare sector. Strategic investments supported by positive...
-
983Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) Staring At A Key Resistance Level
Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) is back to one-year highs after a stellar start to the year. The stock has been on an...
